
Research group at @TU_Muenchen and @HelmholtzMunich focused on HBV immunotherapy and emerging viral infections. Tweets by group members.
Munich, Germany
Joined September 2022
- Tweets103
- Following200
- Followers324
- Likes581
Protzer_Lab retweeted
Are you at #GHS2025?
Come find me at my talks!
So many great sessions on #HBV & #HCV and amazing people to network with.
Great community to work with to achieve #HepatitisElimination by 2030.
Join us Thurs 3-3:30 pm for a #StandUpforHepatitis photo at the #NOhep stand!
Protzer_Lab retweeted
Great to see the energy for @NO_hep #StandUpforHepatitis at #GHS25!
#HepatitisElimination #StandUpforScience #HBV #HCV
Protzer_Lab retweeted
LNP/mRNA therapeutics and AAV-based approaches require cell-level precision to achieve success without significant toxicity to other cells. To enable this, we now introduce SCP-Nano🤗 in @NatureBiotech: an AI-based technology for precision nanotechnology. nature.com/articles/s41587-0…
Protzer_Lab retweeted
We are proud to host the GASL Annual Meeting 2025 from 14-15 February in Munich. The GASL program with fanatastic talks and poster is out now! Here you can find it👇
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
Protzer_Lab retweeted
🎉Speaker Announcement🎉
We’re excited to welcome Alba Monferrer from CPTx to the #VirofightSymposium! CPTx's innovative platform supports multivalent drug development for tackling complex diseases with multiple binding sites, like viruses💡
🔗Register👉 virofight.eu/virofight-sympo…
Protzer_Lab retweeted
The last day of the #immunobiology of viral infections #workshop was scientifically concluded by Dr. Anna Kosinska @TU_Muenchen talking about @TherVacB_EU
#jGfV
@GesVirologie
Protzer_Lab retweeted
Why you should attend #VIROFIGHTSymposium24❔
💡We'll showcase the latest results & achievements of our VIROFIGHT project, highlighting our progress on #antivial biologics off the beaten paths & novel therapeutic approaches to combat viral infections💊
🔗presseportal.de/pm/151581/58…
Protzer_Lab retweeted
BREAKING NEWS
The 2024 #NobelPrize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.
Protzer_Lab retweeted
Along with Laura @DrLauraWolz & Laura @CarterL_J (Laura x3) we have co-founded Carers in STEMM to provide a platform to improve the academic culture for those balancing caring and career in STEMM research.
Give us a follow @stemm_carers and watch this space for the survey 😊
Protzer_Lab retweeted
Congratulations to Sophia Schreiber (@ProtzerLab) and Lisa S. Dessler (@TU_Muenchen) for winning the #PaperOfTheQuarter award presented by @DGGTeV.
Read their work on CARs targeting hepatitis B virus infected cells ⬇️
Protzer_Lab retweeted
The #DGGTeV is delighted to present Sophia Schreiber and Lisa S. Dessler from @ProtzerLab at the @TU_Muenchen the #PaperoftheQuarter #Award for their work to engineer CARs from sorted B cells targeting Hepatitis B.
more here:
dg-gt.de/paper-of-the-quarte…
Protzer_Lab retweeted
23rd workshop of the #jGfV study group "Immunobiology to viral infection" 28.-30.10.24 in Bad Salzschlirf. Deadline September 1st! Great keynote speakers: @janis_mue11er, Hannes Vietzen @MedUni_Wien, Anna Kosinska @ProtzerLab for the @TherVacB_EU
immunviro.g-f-v.org/ (HMB)
Protzer_Lab retweeted
Happy that our joint article with Ulrike Protzer's lab (@ProtzerLab) on the use of AAV vectors for development of HBV mouse models is now out: pubmed.ncbi.nlm.nih.gov/3904… Congrats to 1st author Lisa Schiller, our former MSc student & now PhD student in the Protzer lab 🎊🥂 #AAV #HBV
Protzer_Lab retweeted
📣We are looking for a PhD student to join the team! 📣 If you are interested in unravelling the role of innate-like MAIT cells for viral infections of the liver, send your application! Official announcement to follow…@CellsMait @TRR179_2 images.app.goo.gl/DYYNQw15TV…
Protzer_Lab retweeted
🟪NEW Article in press❕
HBV-related #HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx
🔓#OpenAccess at 👉jhep-reports.eu/article/S258…
#LiverTwitter
#HBV
Protzer_Lab retweeted
1⃣ day to go and #EASL will open its doors!
⏲️Free for 1.5 hours on day 1?
👉Join us to discuss #HBVcure research with @TherVacB_EU 's @UlrikeProtzer @SaSi_Lens Percy Knolle Carolina Boni ➕@IPcureB's @FabienZoulim Pietro Lampertico Massimo Levrero Robert Thimme 🏥🥼💉
@EASLnews
Do you attend #EASLCongress 2024 in Milan🇮🇹? Join our public workshop on #HBVcure research strategies and results with @ipcureb and @TherVacB_EU:
🗓️Wed, 5 June
⏲️4PM CEST
⛳MiCo easlcongress.eu/2024-venue/
@EASLnews @UlrikeProtzer @EU_Health @FabienZoulim @EuropeLiver #LiverTwitter
Protzer_Lab retweeted
Nice read for everyone interested in HBV immunology and the role of HBsAg.
Congrats @ProtzerLab @UlrikeProtzer !
The lack of HBsAg secretion does neither facilitate induction of antiv... sciencedirect.com/science/ar…
Protzer_Lab retweeted
Fighting Epstein-Barr & Hepatitis B Virus
#Vaccine research is pivotal in tackling global health challenges
Prof @UlrikeProtzer & Prof Wolfgang Hammerschmidt at #HelmholtzMunich are making strides in developing innovative vaccines
👉t1p.de/xv5ps
#TherVacB #EpsteinBarr
Protzer_Lab retweeted
Schutz vor Pandemien: Heute wurde ein modernes Hightech-Labor in Augsburg eröffnet!
Mehr zum EU-Projekt PerForM-REACT:
👉t1p.de/szwee
@Traidl_Hoffmann @UlrikeProtzer @IEM_Augsburg @ProtzerLab @uni__augsburg #EFRE
Impressionen im Video 👇
📷Ulrich Wirth
Protzer_Lab retweeted
🎬We are so excited that the first-in-human clinical trial with the TherVacB #vaccine candidate in #healthy volunteers has started.
🚀In parallel, we are currently preparing the launch of our eagerly awaited first #clinical study in #chronic #HBV #patients.
@NO_hep #livertwitter
Battling Chronic #HepatitisB
TherVacB, a therapeutic vaccine, is now in clinical trial. Developed by #HelmholtzMunich, phase 1a at @Tropeninstitut & sponsored by @UKEHamburg evaluates safety & immunogenicity in healthy volunteers.💉
👉t1p.de/9mqce
@UlrikeProtzer




































